• Melanoma
    Categories: ,

    Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

    24 May 2022

  • Categories: ,

    EORTC and Alliance Healthcare’s continued partnership in support of SPECTA clinical research infrastructure

    19 May 2022

  • Radiotherapy Quality Assurance Manager illustration
    Categories:

    Results of radiotherapy quality assurance in the PEACE-1 trial show high adherence to protocol

    10 May 2022

  • Precision Medicine
    Categories:

    EORTC presents new precision medicine research results at AACR 2022

    13 Apr 2022

  • EMA - EORTC Workshop
    Categories:

    Joining forces to optimise cancer treatments in clinical practice: EMA & EORTC launch Cancer Medicines Forum with academia

    1 Apr 2022

  • Lung
    Categories: , ,

    MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression

    17 Mar 2022

  • Mindact Breast Cancer
    Categories: ,

    Promising results for the ultra-low risk patient group in latest MINDACT analysis

    27 Jan 2022

  • NWOW
    Categories:

    New Ways of Working in a new era: EORTC new hybrid work model based on collaboration and flexibility

    19 Jan 2022